Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
UBLFSMURWWWWMH
|
9.1 | IC50 | 7 | — | |
VBTNLJJWTKVDJI
|
9.1 | IC50 | 2 | — | |
VNVKSDCWJDOWNE
|
9.1 | IC50 | 3 | — | |
XVNLBZLPZWXFED
|
9.1 | IC50 | 2 | — | |
LAENBVFKZYAQJP
|
9.1 | IC50 | 2 | — | |
JPWPFXUIMVYLLR
|
9.1 | IC50 | 3 | — | |
QGFZDGFJYXGLAW
|
9.1 | IC50 | 3 | — | |
RUUPXYQCYGGBFU
|
9.1 | IC50 | 2 | — | |
NIOMHCDHWWSVMY
|
9.0 | Ki | 3 | — | |
SHEVKZDATWMHOR
|
9.0 | IC50 | 2 | — | |
HRJWTAWVFDCTGO
|
9.0 | IC50 | 13 | Yes | |
BSHCILRNXWKQAL
|
9.0 | IC50 | 2 | — | |
CXHLTNFGZLWOKU
|
9.0 | Ki | 3 | Yes | |
DJAGWSNSAWJXLX
|
9.0 | IC50 | 2 | — | |
HSDHAJSZFGKELI
|
9.0 | IC50 | 2 | — | |
IBMFJBCXKFJOPZ
|
9.0 | IC50 | 2 | — | |
JWHUZKCDLIXMSE
|
9.0 | IC50 | 4 | — | |
KIJWMPSSOUHQTQ
|
9.0 | Ki | 3 | Yes | |
KZIAOAADZPTJQN
|
9.0 | Ki | 4 | — | |
PHIYRFJMMCWKIZ
|
9.0 | IC50 | 2 | — | |
QMPGWYFQWWEQDM
|
9.0 | IC50 | 2 | — | |
RQZPNTQBUCGKFA
|
9.0 | IC50 | 2 | — | |
VVOFXGOUMCCSEE
|
9.0 | IC50 | 2 | — | |
WIIIHAKKVLVGJX
|
9.0 | IC50 | 3 | Yes | |
WKITVSVNTNNVLF
|
9.0 | IC50 | 3 | Yes | |
GHFQRLZWDHJYKZ
|
9.0 | IC50 | 2 | — | |
KVVPUEYLAZZLFF
|
9.0 | IC50 | 3 | — | |
NDAFUJBJGDJBNC
|
9.0 | IC50 | 3 | — | |
YUFANAGBOIXUIR
|
9.0 | IC50 | 2 | — | |
PEJAKFMXABEULA
|
8.9 | IC50 | 2 | — | |
UFOSROJETSAJRO
|
8.9 | IC50 | 2 | — | |
NIOMHCDHWWSVMY
|
8.9 | Ki | 3 | — | |
FANYLTZIIIZQJA
|
8.9 | Ki | 4 | — | |
HPDNAGAYFYNQBT
|
8.9 | IC50 | 2 | — | |
INJUVNWOFHYUIN
|
8.9 | IC50 | 9 | Yes | |
OQKSXFCBEUFFIJ
|
8.9 | IC50 | 2 | — | |
JCTOCSMGNIHFPY
|
8.9 | IC50 | 2 | — | |
AWXGVFDBNXCKQV
|
8.8 | IC50 | 2 | — | |
BFXPDORMGAUHQH
|
8.8 | Ki | 3 | — | |
DDBPEXIOZILUTR
|
8.8 | IC50 | 2 | — | |
UGFCXJZAFXTHCY
|
8.8 | IC50 | 2 | — | |
WWEHEGICBBJKLI
|
8.8 | IC50 | 3 | — | |
YYEIHROTXDFNIC
|
8.8 | IC50 | 2 | — | |
CIUATZJWGJGLPW
|
8.8 | IC50 | 4 | — | |
DHZZLYIYWJJLRB
|
8.8 | IC50 | 3 | — | |
FQGBFYNAGSGZFG
|
8.8 | IC50 | 2 | — | |
BMXGRFBSHSEZOP
|
8.8 | IC50 | 5 | Yes | |
DRDJBBZKDSVNTH
|
8.8 | IC50 | 2 | — | |
NYNFHQSIJDCJQN
|
8.8 | IC50 | 2 | — | |
PTABJNPXSUGRKA
|
8.8 | IC50 | 2 | — |